Lyophilization has been popularly employed by the pharmaceuticals industry in parenteral product development. The process has the potential to improve the shelf-life, increase the efficacy of formulations, especially complex injectables, and to make them easier to store and transport. Biopharmaceutical companies adopt lyophilization services for manufacturing sterile lyophilized bulk APIs and drug products. They are gaining popularity for complex biologics. The drive for the lyophilization services for biopharmaceuticals market stems from the inclination and efforts by the industry world over to comply with good manufacturing practices (cGMP).